Cargando…

Darolutamide for prostate cancer

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572188/
https://www.ncbi.nlm.nih.gov/pubmed/33093746
http://dx.doi.org/10.18773/austprescr.2020.061
_version_ 1783597292674088960
collection PubMed
description
format Online
Article
Text
id pubmed-7572188
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-75721882020-10-21 Darolutamide for prostate cancer Aust Prescr New Drugs NPS MedicineWise 2020-08-28 2020-10 /pmc/articles/PMC7572188/ /pubmed/33093746 http://dx.doi.org/10.18773/austprescr.2020.061 Text en (c) NPS MedicineWise http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Darolutamide for prostate cancer
title Darolutamide for prostate cancer
title_full Darolutamide for prostate cancer
title_fullStr Darolutamide for prostate cancer
title_full_unstemmed Darolutamide for prostate cancer
title_short Darolutamide for prostate cancer
title_sort darolutamide for prostate cancer
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572188/
https://www.ncbi.nlm.nih.gov/pubmed/33093746
http://dx.doi.org/10.18773/austprescr.2020.061